tegobuvir

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Hepatitis C, Chronic

Phase 2

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

CompletedNCT01353248

Gilead SciencesHepatitis C, Chronic

Start: 2011-05-31End: 2013-03-31Updated: 2013-12-20

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

CompletedNCT01435226

Gilead SciencesHepatitis C, Chronic

Start: 2011-09-30End: 2013-07-31Updated: 2013-12-17